Dr. Guy Van Hazel on Selective Internal Radiation Therapy and its Effects on Extrahepatic Colorectal Cancer
Dr. Guy Van Hazel speaks about finding a potential survival advantage for extrahepatic colorectal cancer metastases patients that undergo selective internal radiation therapy.
Guy Van Hazel, MD, Medical Oncologist, Mount Hospital and School of Medicine University of Western Australia, speaks about finding a potential survival advantage for extrahepatic colorectal cancer (CRC) metastases patients that undergo selective internal radiation therapy (SIRT).
Survival data is not yet available. However, for patients that underwent SIRT, time to progression of liver metastases was 7.9 or 8 months; which Van Hazel says is significant and could be indicative of a possible survival benefit in further studies.
Enasidenib Shows Promise as Post-Transplant Maintenance in IDH2-Mutated AML
January 7th 2025Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic stem cell transplant maintenance therapy for IDH2-mutated acute myeloid leukemia treatment.
Read More
